Targeting SRSF7 offers potential therapy for pulmonary fibrosis

Post author:admin
Post published:July 10, 2025
Post category:uncategorized

This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Combining MRI and blood tests to avoid unnecessary prostate biopsies

Recipe Roundup: Diabetes-Friendly Smoothies

UMSOM wins $3.5 million BARDA contract to develop animals models for radiation research

Helpful Links

Subscribe To Us